ArticleQatar medical journal2026
Parinaud's syndrome in posterior stroke treated with intravenous thrombolysis: A case report.
Article in Qatar medical journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Parinaud's syndrome, or dorsal midbrain syndrome, is characterized by vertical gaze palsy, light-near dissociation, convergence-retraction nystagmus, and bilateral eyelid retraction. The majority of cases are caused by pineal region tumors, whereas vascular etiologies are less frequent. Early recognition of this neuro-ophthalmological syndrome can be crucial for diagnosing brainstem strokes, particularly when initial neuroimaging findings are normal. Case presentation: A 66-year-old man presented to the Emergency Department with sudden-onset vertical diplopia, dysarthria, and gait instability, consistent with an acute neurological event. Neuro-ophthalmological examination revealed the complete classical triad of Parinaud's syndrome. Brain magnetic resonance imaging (MRI) and computed tomography angiography (CTA) showed no acute ischemic lesions or vascular abnormalities. Given the disabling oculomotor findings and the strong suspicion of posterior circulation ischemia, intravenous thrombolysis with recombinant tissue plasminogen activator (rtPA) was administered within 3.5 h of symptom onset. The patient achieved complete neurological and oculomotor recovery within 24 h, and follow-up brain MRI confirmed the absence of structural damage. Discussion: The present case illustrates Parinaud's syndrome, a rare neuro-ophthalmological manifestation of acute posterior circulation ischemia, treated with intravenous thrombolysis. Although its global prevalence remains unknown, published series show that the syndrome is exceptionally uncommon, with vascular etiologies representing approximately 25% of cases-making stroke the second most common cause after pineal region tumors.In contrast to pineal region tumors, which typically produce a slowly progressive clinical course, vascular etiologies are characterized by abrupt symptom onset. Conclusion: This case underscores the importance of recognizing Parinaud's syndrome as a possible manifestation of posterior circulation ischemia, particularly when early neuroimaging findings appear normal. Its rarity and atypical presentation can make therapeutic decision-making challenging in the acute setting, highlighting the diagnostic value of a meticulous ocular examination.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.